Who is sponsoring NCT06775080?

NCT06775080 is sponsored by Huashan Hospital.

What drugs are being tested in NCT06775080?

Interventions in NCT06775080: propranolol (beta-blocker used treat high blood pressure).

What condition does NCT06775080 study?

NCT06775080 studies Gastrointestinal Tumors.

Is NCT06775080 still recruiting?

NCT06775080 is currently recruiting now. Last updated 14 January 2025.

Last reviewed 2025-01-14 · How we verify

NCT06775080

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Use of Propranolol in the Perioperative Period of Resectable Gastrointestinal Tumors

Recruiting now Phase 2 Last updated 14 January 2025

What this trial tests

Phase 2 trial testing propranolol (beta-blocker used treat high blood pressure) in Gastrointestinal Tumors in 40 participants. Currently enrolling.

Timeline

1 December 2024

Primary endpoint
31 December 2026

30 April 2027

Quick facts

Lead sponsor	Huashan Hospital
Phase	Phase 2
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	40
Start date	1 December 2024
Primary completion	31 December 2026
Estimated completion	30 April 2027
Sites	1 location across China

Drugs / interventions tested

propranolol (beta-blocker used treat high blood pressure) — full drug profile →

Conditions studied

Gastrointestinal Tumors — all drugs for Gastrointestinal Tumors →

Sponsor

Huashan Hospital

Who can join

Adults 18 to 65, any sex, with Gastrointestinal Tumors. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, perioperative propranolol β-blockade was administered to patients with surgically resectable primary gastrointestinal tumors to explore the safety, efficacy, and alleviation of perioperative psychological stress. At the same time, a multi-omics study was conducted using clinical samples to explore the activation of anti-tumor immune response and its mechanism.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Peripheral Nerves in Cancer: Regulatory Roles and Therapeutic Strategies.
Fu Y, Ge ZS, Cao QY, Li ZH, et al · · 2026 · cited 1× · PMID 41556039 · DOI 10.1002/mco2.70594
Cancer Neoaxonogenesis: Mechanisms and Factors Involved in the Recruitment of Peripheral Nerves by Cancer Tissue.
Blasko F, Horvathova L, Hunakova L, Krivosikova L, et al · · 2026 · PMID 42123376 · DOI 10.3390/ijms27093792

Verify or expand the search:

Other recruiting trials for Gastrointestinal Tumors

Currently open trials in the same condition.

NCT07067385 — Personalized mRNA Cancer Vaccine for Gastrointestinal Solid Tumor Treatment · Phase 1 · recruiting
NCT07104877 — A Study of SYS6010 in Combination With SYH2051 in Patients With Advanced Colorectal Cancer and Other Gastrointestinal Tu · NA · active not recruiting
NCT06152757 — BGT007H Cells for the Treatment of Recurrent/Refractory Gastrointestinal Tumors · EARLY_PHASE1 · recruiting
NCT06478030 — Combined Screening for Gastrointestinal Tumors · recruiting
NCT03833700 — A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC) · Phase 1 · active not recruiting

Other Huashan Hospital trials

Trials by the same sponsor.

NCT07469735 — Vorasidenib Guided by AGX PET in Recurrent/Low-grade Glioma · NA · not yet recruiting
NCT07364487 — This is an Open-Label Study to Assess the Safety and Efficacy of GC012F in Patients With Multiple Sclerosis · EARLY_PHASE1 · withdrawn
NCT07369830 — The Impact of Probiotic Intervention on the Gut Microbiota and Bowel Function · NA · recruiting
NCT07185373 — Orelabrutinib Combined With Teniposide, Rituximab and Methotrexate for Newly Diagnosed PCNSL · Phase 2, PHASE3 · not yet recruiting
NCT07075029 — RSV in Acute Respiratory Infection Surveillance Among Community-Dwelling Elderly Aged ≥50 Years in China · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06775080 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Huashan Hospital
Last refreshed: 14 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06775080.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing